RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway
Jing Lv(Wuhan City Chinese Medicine Hospital), Chaoxian Yang(Southwest Medical University), Jiming Kong(University of Manitoba), Yan Zhu(Fudan University), Li Deng(Southwest Medical University), Qiang You(Southwest Medical University), Kan Guo(Southwest Medical University), Xiaoqing Gao(Southwest Medical University), Weikang Guan(Southwest Medical University)
Cited by 58
Related Papers
Renoprotective role of the vitamin D receptor in diabetic nephropathy
|Kidney International|2007|305
BNIP3 Interacting with LC3 Triggers Excessive Mitophagy in Delayed Neuronal Death in Stroke
|CNS Neuroscience & Therapeutics|2014|272
Recent Advances in Nanotheranostics for Treat‐to‐Target of Rheumatoid Arthritis
|Advanced Healthcare Materials|2020|65
<p>Dexmedetomidine attenuates the neurotoxicity of propofol toward primary hippocampal neurons in vitro via Erk1/2/CREB/BDNF signaling pathways</p>
|Drug Design Development and Therapy|2019|64
Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k/Akt/GSK3β pathway in the hippocampus of neonatal rats
|Environmental Toxicology and Pharmacology|2017|59